With this programmable platform, the initial application of chip-based multianalyte detection systems for cardiac applications was completed by targeting two inflammatory biomarkers, C-reactive protein (CRP) and interleukin-6 (IL-6), both relevant to the cardiac disease cascade [71]. The gene discussed is CRP; the disease is heart disorder.